Patents by Inventor Frederich-Wilhelm Kuhne

Frederich-Wilhelm Kuhne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized Chlorite Solutions in Combination with Fluoropyrimidines for Cancer Treatment
    Publication number: 20080292729
    Abstract: Pharmaceutical compositions for treating neoplastic disorders and uses thereof are provided. Said pharmaceutical compositions comprise stabilized chlorite solutions (e.g. WFIO) and a fluoropyrimidine, 5-FU, or a 5-FU prodrug (e.g. capecitabine, doxifluridine, UFT, S-1, or BOF-A2). The use of the above stabilized chlorite solution in combination with a fluoropyrimidine dramatically improves the quality of life index (QOL) of a patient undergoing cancer chemotherapy. Cancers that can be treated include cancers of the pancreas, gastrointestinal, head, neck, and breast.
    Type: Application
    Filed: July 21, 2006
    Publication date: November 27, 2008
    Applicant: NUVO RESEARCH INC.
    Inventors: Stefan Meuer, Thomas Giese, Frederich-Wilhelm Kuhne
  • Evaluating and predicting clinical outcomes by gene expression analysis
    Publication number: 20040224306
    Abstract: Methods of determining clinical outcomes in patients suffering from a pathological condition or syndrome are provided. Levels of intracellular gene expression are measured from a clinical sample provided by the patient, and the levels are compared to reference levels. Deviations from reference levels are predictive of clinical outcomes, for example, disease progression or response to therapeutic intervention.
    Type: Application
    Filed: October 15, 2002
    Publication date: November 11, 2004
    Inventors: Frederich-Wilhelm Kuhne, Michael MCGrath, Stefan Meuer